Search Clinical Trials
596,361 trials
ID
Status
Phase
Title
Sponsor
NCT07739355
Comparison of Efficacy and Safety Profile Between Moisturizers Containing a Combination of 5% Hydro-Urea, Ceramide, With MultiVesicular Emulsion Technology and Petrolatum on Dry Skin in the ElderlyDr. dr. Lili Legiawati, SpKK(K)CompletedPhase 3
NCT07739355Completed
Phase 3
Comparison of Efficacy and Safety Profile Between Moisturizers Containing a Comb...Dr. dr. Lili Legiawati, S...
NCT07738211
Laughter Yoga, Emotional Labor, and Menopause-Specific Quality of Life in NursesInonu UniversityActive Not RecruitingNot Applicable
NCT07738211Active Not Recruiting
Not Applicable
Laughter Yoga, Emotional Labor, and Menopause-Specific Quality of Life in NursesInonu University
NCT07739277
Transverse vs. Longitudinal Serratus Anterior Plane Block in Breast SurgeryAnkara Etlik City HospitalNot Yet RecruitingNot Applicable
NCT07739277Not Yet Recruiting
Not Applicable
Transverse vs. Longitudinal Serratus Anterior Plane Block in Breast SurgeryAnkara Etlik City Hospita...
NCT07740551
Comparison of Individuals With Primary Ciliary Dyskinesia and Healthy ControlsIzmir Democracy UniversityNot Yet Recruiting
NCT07740551Not Yet Recruiting
—
Comparison of Individuals With Primary Ciliary Dyskinesia and Healthy ControlsIzmir Democracy Universit...
NCT07739199
A Study Comparing BL-B01D1 in Combination With PD-1/VEGF Bispecific Antibody Versus Chemotherapy in Combination With PD-1/VEGF Bispecific Antibody in First-line Patients With Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer(PANKU-Lung05)Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 2
NCT07739199Not Yet Recruiting
Phase 2
A Study Comparing BL-B01D1 in Combination With PD-1/VEGF Bispecific Antibody Ver...Baili-Bio (Chengdu) Pharm...
NCT07738614
A Study of Eloralintide (LY3841136) in Participants With Obesity or OverweightEli Lilly and CompanyNot Yet RecruitingPhase 1
NCT07738614Not Yet Recruiting
Phase 1
A Study of Eloralintide (LY3841136) in Participants With Obesity or OverweightEli Lilly and Company
NCT07739186
A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer(PANKU-Lung06)Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 2
NCT07739186Not Yet Recruiting
Phase 2
A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody...Baili-Bio (Chengdu) Pharm...
NCT07738276
Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Patients With ObesityShahid Beheshti University of Medical SciencesNot Yet RecruitingPhase 3
NCT07738276Not Yet Recruiting
Phase 3
Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist,...Shahid Beheshti Universit...
NCT07738367
Bronchial Artery Chemoembolization (BACE) Combination Therapy for Advanced NSCLCFujian Cancer HospitalEnrolling By InvitationPhase 2
NCT07738367Enrolling By Invitation
Phase 2
Bronchial Artery Chemoembolization (BACE) Combination Therapy for Advanced NSCLCFujian Cancer Hospital
NCT07738640
Effects of Two Endurance Training Programs on 5-km Running Performance in Recreational RunnersShuqi JiaNot Yet RecruitingNot Applicable
NCT07738640Not Yet Recruiting
Not Applicable
Effects of Two Endurance Training Programs on 5-km Running Performance in Recrea...Shuqi Jia
NCT07738237
Clinical Evaluation of Hearing Aid OTC Self-Assessment Methods for Adults With Perceived Mild-to-Moderate Hearing LossGlobal Edge Medtech ConsultingNot Yet RecruitingNot Applicable
NCT07738237Not Yet Recruiting
Not Applicable
Clinical Evaluation of Hearing Aid OTC Self-Assessment Methods for Adults With P...Global Edge Medtech Consu...
NCT07739719
SAFE (Self-Administration of Flumist to ImprovE Uptake: A Household-Based Cluster Randomized Trial)McMaster UniversityNot Yet RecruitingPhase 4
NCT07739719Not Yet Recruiting
Phase 4
SAFE (Self-Administration of Flumist to ImprovE Uptake: A Household-Based Cluste...McMaster University
NCT07738315
Elemene Liposomes in Endometrial CancerBeijing Friendship HospitalNot Yet RecruitingPhase 2
NCT07738315Not Yet Recruiting
Phase 2
Elemene Liposomes in Endometrial CancerBeijing Friendship Hospit...
NCT07738653
Changes in Spatiotemporal Gait Parameters in Experienced MeditatorsFundacion PodoactivaCompletedNot Applicable
NCT07738653Completed
Not Applicable
Changes in Spatiotemporal Gait Parameters in Experienced MeditatorsFundacion Podoactiva
NCT07739043
NeuroRise: Intrathecal CE-1 Treatment for Traumatic SCICell Therapy LLCNot Yet RecruitingEarly Phase 1
NCT07739043Not Yet Recruiting
Early Phase 1
NeuroRise: Intrathecal CE-1 Treatment for Traumatic SCICell Therapy LLC
NCT07740148
Human-Created vs AI-generated Art on Immediate Psychological ResponsesStanford UniversityNot Yet RecruitingNot Applicable
NCT07740148Not Yet Recruiting
Not Applicable
Human-Created vs AI-generated Art on Immediate Psychological ResponsesStanford University
NCT07738757
SKB264 Plus KL-A167 in MSI-H/dMMR Advanced Gynecological MalignanciesPeking Union Medical College HospitalNot Yet RecruitingPhase 2
NCT07738757Not Yet Recruiting
Phase 2
SKB264 Plus KL-A167 in MSI-H/dMMR Advanced Gynecological MalignanciesPeking Union Medical Coll...
NCT07739472
Mobile Application-Supported Education in Nursing StudentsMaltepe UniversityCompletedNot Applicable
NCT07739472Completed
Not Applicable
Mobile Application-Supported Education in Nursing StudentsMaltepe University
NCT07738224
Using the Babble Boot Camp© Speech Therapy Approach With Babies Born PrematurelyMurdoch Childrens Research InstituteNot Yet RecruitingNot Applicable
NCT07738224Not Yet Recruiting
Not Applicable
Using the Babble Boot Camp© Speech Therapy Approach With Babies Born PrematurelyMurdoch Childrens Researc...
Result Breakdown
Not yet recruiting14 (70%)
Completed3 (15%)
Active, not recruiting1 (5%)
Recruiting1 (5%)
Enrolling by invitation1 (5%)
not_applicable8 (40%)
Phase 25 (25%)
Phase 32 (10%)
Not Specified2 (10%)
Phase 11 (5%)
Phase 41 (5%)
Early Phase 11 (5%)